Previous studies have also found associations between the level of CD4+ T cells and disease severity in MS, PD, stroke, AD, and other neurological diseases,14, 15, 16 so the count of CD4+ T cells altered in the periphery or CNS may be an effective index for monitoring the disease process for RIBI patients. Here, CD4 is linked to myeloid sarcoma.